A new real-world analysis from UK drugmaker Indivior (Nasdaq: INDV) suggests that patients with opioid use disorder (OUD) ...

A major US trial has found that structured healthy lifestyle programs can slow memory loss in older adults, regardless of ...

Eli Lilly today announced positive top-line results from the Phase III BRUIN CLL-314 clinical trial of Jaypirca ...

Privately-held Italian pharma company Alfasigma has announced positive topline results from the OLINGUITO Phase III trial of ...

Russia is currently experiencing a strong increase in the sales of drugs against alcoholism, as the number of citizens, who ...

US pharma giant Merck & Co was trading 4% lower in pre-market Tuesday after the group presented its second quarter 2025 ...

US pharma major Bristol Myers Squibb and Bain Capital announced the creation of a new independent biopharmaceutical company ...

US biotech PTC Therapeutics’ shares trading up 4.8% to $46.48 in after-hours activity yesterday, as it announced that the US ...

Family-owned Boehringer Ingelheim, now Germany’s largest drugmaker by revenue, has reported positive growth in the first half ...

The US Food & Drug Administration (FDA) has approved Danish biotech Ascendis Pharma’s Skytrofa (lonapegsomatropin-tcgd; ...

Sarepta Therapeutics (Nasdaq: SRPT) has been cleared by the American medicines regulator to resume shipments of its gene ...

AstraZeneca (LSE: AZN) posted a robust second-quarter 2025 performance, lifted by record growth in its US business and solid ...